| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
147 |
| issn |
1948-5875 |
| issueIdentifier |
2 |
| pageRange |
147-147 |
| publicationName |
ACS Medicinal Chemistry Letters |
| startingPage |
147 |
| bibliographicCitation |
Rosse G. Diazaspirononane Inhibitors of O-GlcNAc Hydrolase for the Treatment of Central Nervous System Diseases. ACS Med. Chem. Lett. 2019 Jan 04;10(2):147. doi: 10.1021/acsmedchemlett.8b00653. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1993-3575 |
| date |
2019-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/30783492
https://doi.org/10.1021/acsmedchemlett.8b00653
https://pubmed.ncbi.nlm.nih.gov/PMC6378660 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641
https://portal.issn.org/resource/ISSN/1948-5875 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Diazaspirononane Inhibitors of O-GlcNAc Hydrolase for the Treatment of Central Nervous System Diseases |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7203
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.2.1.169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439174
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_857c6674a8be6658c6e9a1eff2ae44ab |